Adial Pharmaceuticals Inc (NASDAQ:ADIL)

Adial Pharmaceuticals Inc (NASDAQ:ADIL)

Share Price
$ 1.95
-0.02 (-1.02 %)
Market Cap
$19.93 m
Proactive Investors - Run By Investors For Investors

Adial Pharmaceuticals Inc

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder “AUD” using our lead investigational new drug product, AD04. A Phase 2b University of Virginia investigator sponsored clinical trial of AD04 for the treatment of AUD showed promising results and no overt safety concerns (there were...

52-week High/Low: $9.44 / $1.11
Sector: Health Care, Equipment & Services
Market Cap: $19.93 m
col 3
col 4
col 5
col 6

Adial Pharmaceuticals Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use